Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;25(11):1209.
doi: 10.1111/resp.13939. Epub 2020 Sep 20.

Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern

Karolina Akinosoglou  1 , Charalambos Gogos  1
Affiliations
Comment

Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern

Karolina Akinosoglou et al. Respirology. 2020 Nov.

Abstract

See related reply

PubMed Disclaimer

Comment in

  • Reply.
    Savinelli S, McCarthy C, Mallon PW; All Ireland Infectious Diseases (AIID) Cohort Collaborators. Savinelli S, et al. Respirology. 2020 Nov;25(11):1210-1211. doi: 10.1111/resp.13940. Epub 2020 Sep 20. Respirology. 2020. PMID: 32954555 Free PMC article.

Comment on

References

    1. McCarthy C, Savinelli S, Feeney ER, Butler MW, O'Broin C, Ryan S, O'Neill L, Murphy DJ, Gallagher CG, McKone EF et al. Tocilizumab therapy in individuals with COVID‐19 infection and hyperinflammatory state. Respirology 2020; 25: 1090–4. - PMC - PubMed
    1. Keske Ş, Tekin S, Sait B, İrkören P, Kapmaz M, Çimen C, Uğur S, Çelebi I, Oğuzalp Bakır V, Palaoğlu E et al. Appropriate use of tocilizumab in COVID‐19 infection. Int. J. Infect. Dis. 2020; S1201‐9712(20):30580–4. 10.1016/j.ijid.2020.07.036. - DOI - PMC - PubMed
    1. Canziani LM, Trovati S, Brunetta E, Testa A, De Santis M, Bombardieri E, Guidelli G, Albano G, Folci M, Squadroni M et al.; Humanitas, Gavazzeni/Castelli C‐TF . Interleukin‐6 receptor blocking with intravenous tocilizumab in COVID‐19 severe acute respiratory distress syndrome: a retrospective case‐control survival analysis of 128 patients. J. Autoimmun. 2020. 10.1016/j.jaut.2020.102511. - DOI - PMC - PubMed
    1. Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B. Tocilizumab (Actemra). Hum. Vaccin. Immunother. 2017; 13: 1972–88. - PMC - PubMed